According to the current issue of the Bulletin of the World Health Organization the highest number of new HIV cases since reporting began in the 1980s was recorded in WHO’s European Region in 2014, according to the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe.
The Global Fund, a partnership that sends HIV drugs to poor countries, says it plans to send an advance supply of antiretroviral therapy to Uganda, after the East African country ran out three months before the end of last year.
RED, the AIDS organization founded by Bono and Bobby Shriver announced that the Gates Foundation,will match up to $50 million of any funds raised to fight AIDS.
Two years after sexual minorities in India were dealt a terrible setback by the Supreme Court, more elected politicians are stepping up for L.G.B.T. rights.
Fewer than 1 in 4 high school students who’ve had sex have ever been tested for HIV, a troubling low rate that didn’t budge over eight years, government researchers say. Young adults fared slightly better, although testing rates have declined in black women, a high-risk group.
“Supporting and Monitoring ART Initiation and Adherence in Resource-Constrained Settings.”
Robert H. Remien, Ph.D., is Director of the HIV Center for Clinical and Behavioral Studies in the Division of Gender, Sexuality, and Health and is Professor of Clinical Psychology (in Psychiatry) at Columbia University. Dr. Remien is also Director of the HIV Center’s Administrative Core, Faculty Mentor for HIV Center Postdoctoral Fellows, and Clinical Supervisor to psychiatric residents in training. His research is focused on mental health, sexual risk behavior, and adherence to treatment and care, and he has developed and tested several behavioral interventions in these domains in both domestic and international settings.
As a researcher in the HIV Center from its beginnings, he has published numerous articles on psychopathology and psychological resilience, psychoimmunology, coping and adaptation to chronic illness among individuals, couples, and families, sexual and health behaviors, long-term survival with HIV/AIDS, and acute HIV-infection. Dr. Remien has worked to facilitate numerous collaborations and partnerships among health departments, community-based organizations, and clinic sites on behalf of the HIV Center and its investigators throughout its history.
He has served as Chair for the New York State Psychological Association’s Task Force on AIDS, a member of the New York City’s Department of Health Prevention Planning Group, and senior faculty for the American Psychological Association’s HIV training program for psychologists. He also maintains a part-time private practice in clinical psychology in Manhattan.
A study recently published in the concluded that taking pre-exposure propyhlaxis for the prevention of HIV was as safe as aspirin.
Researchers from the University of California, Los Angeles compared five major studies on PrEP for HIV infection and two major studies on aspirin safety.
The study was conducted and written by Noah Kojima, a second year medical student at the David Geffen School of Medicine at UCLA, and Dr. Jeffrey Klausner, professor of medicine in the division of infectious diseases at the David Geffen School of Medicine at UCLA and of public health at the UCLA Fielding School of Public Health.
Kenneth H. Mayer, M.D.
Professor of Medicine, Harvard Medical School, Medical Research Director, Fenway Health; Director of HIV Prevention Research, Beth Israel Deaconess Medical Center
“A New Normal?: Sexual Health and Sexually Transmitted Infections in the Antiretrovirals for Prevention Era”
